Jazz Pharmaceuticals(JAZZ) - 2026 Q1 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2026 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (State or other jurisdiction of incorporation or organization) Ireland 98-1032470 (I.R.S. Employer Identification No.) Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland D04 E ...